HETEROARYL COMPOUNDS AS EGFR INHIBITORS AND THEIR USES
申请人:Accutar Biotechnology Inc.
公开号:US20240059698A1
公开(公告)日:2024-02-22
Disclosed are heteroaryl compounds and pharmaceutical compositions thereof, which are useful for inhibiting EGFR, as well as methods for using such compounds to treat cancer associated with an EGFR or HER2 exon 20 insertion mutation.
US2023/87342
申请人:——
公开号:——
公开(公告)日:——
Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands
申请人:Merck Sharp & Dohme Limited
公开号:US06200975B1
公开(公告)日:2001-03-13
Substituted 1,2,4-Triazolo[3,4-A]phthalazine derivatives are GABA Alpha 5 ligands and are represented by the formula